Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
about
Positron Emission Tomography in Breast CancerRadionuclide methods and instrumentation for breast cancer detection and diagnosis.Positron emission tomography-magnetic resonance imaging: technical review.Advances in molecular imaging for breast cancer detection and characterizationMeta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapyMeta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapyNuclear imaging of the breast: translating achievements in instrumentation into clinical useInterpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibilityClinical utility of positron emission mammography.Clinical practice guideline for dedicated breast PETPositron Emission Mammography Imaging with Low Activity Fluorodeoxyglucose and Novel Utilization in Core-needle Biopsy SamplingThe emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelinesMultiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response AssessmentMolecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.Analytical study of the effect of the system geometry on photon sensitivity and depth of interaction of positron emission mammography.Collimator design for a dedicated molecular breast imaging-guided biopsy system: proof-of-concept.Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.Positron emission mammography (PEM): reviewing standardized semiquantitative methodThe current status of positron emission mammography in breast cancer diagnosis.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Role of imaging in neoadjuvant therapy for breast cancer.Comparison of diffusion-weighted MR imaging and FDG PET/CT to predict pathological complete response to neoadjuvant chemotherapy in patients with breast cancer.Present and future role of FDG-PET/CT imaging in the management of breast cancer.Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.Positron emission mammography (PEM): effect of activity concentration, object size, and object contrast on phantom lesion detection.18F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.Potential Clinical Applications of 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer.MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.Can positron emission mammography help to identify clinically significant breast cancer in women with suspicious calcifications on mammography?Dedicated Breast Gamma Camera Imaging and Breast PET: Current Status and Future Directions
P2860
Q26768486-5CF8105A-4293-4857-A0DA-48B441E75F10Q26823614-304FE569-B506-480D-A97B-CC8DA118E326Q26998059-56A98719-1D00-41D3-9977-2CDFBF860452Q27000462-552BFF4E-69D8-4773-982E-0FC3D5CC6E43Q27024544-0D9EBB3B-1F65-4D2A-B0A1-706FCEE53DC6Q27027281-8A3338FF-39E5-404E-995F-61E24CE389F3Q30419180-7F9E8C41-07D1-405A-A1D7-87E93EFBAEB0Q33654503-0E6E8F3B-AB36-45AD-AEB7-8690F019C39FQ34354581-9EBC6296-A619-46DF-95F4-A1F5F2BB0F3DQ35083649-C86B4CE8-81D3-45C0-ACDC-E1DEE384E268Q35109408-18F534DC-3957-4230-8241-E7B62F143C8EQ35697644-79F20247-95F5-43CF-87B0-014033F6D422Q35784966-E46982F9-4A80-4A87-BD80-013F633E0703Q36104568-384C59A9-1274-400B-8E9D-388A971E0C3CQ36282621-0B9C79DB-9EF9-4E89-A01B-83236A6A4C18Q36510676-D2A19833-042D-488D-A759-76625DACE138Q37283386-B690BDDF-0154-40B2-AF9F-53FB36EEBCABQ37314333-C90A26E6-3581-4B4A-AE3F-54E6E15462CCQ38067336-BD544FD0-8CC0-462B-A21F-44E5E0292D73Q38090509-AA560DAB-58AA-442B-9F3E-992CAC6CDC69Q38366386-83875CC4-4513-4D17-BBEE-0E67AB66B4A7Q38471361-A7293112-0878-4C47-8F97-2705CCA318EEQ38687620-598D68CF-41F9-404C-9459-0A772540007FQ44456340-C5B69422-4F22-4E6A-AF6B-3118407597D4Q47280625-446B87C9-2443-479E-9B4D-A8409D4E05E2Q47346434-0369E29F-42D9-4720-B5EA-89D351FC7074Q47961966-E5FA5DDC-F083-4EBA-B390-F33DD9BD5E45Q50996001-C4BB8DB7-7552-4D3C-B807-CF401B032047Q53093553-62B19D24-54D0-416E-B48E-100105D9E509Q54442501-5AD0370E-5E91-4295-8282-061218C9C114Q57178839-EC572273-8865-45B7-8F2A-22A48E56ECC5
P2860
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@ast
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@en
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@nl
type
label
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@ast
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@en
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@nl
prefLabel
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@ast
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@en
Breast cancer: comparative eff ...... ng for the ipsilateral breast.
@nl
P2093
P2860
P356
P1433
P1476
Breast cancer: comparative eff ...... ing for the ipsilateral breast
@en
P2093
Deepa Narayanan
Etta D Pisano
Joel P Miller
Judith E Kalinyak
Kathleen S Madsen
Kathy Schilling
Linda Hovanessian Larsen
Marie Tartar
Wendie A Berg
P2860
P356
10.1148/RADIOL.10100454
P407
P50
P577
2010-11-12T00:00:00Z